Détention brevets de la classe C07D 235/10

Brevets de cette classe: 111

Historique des publications depuis 10 ans

7
9
9
7
8
8
5
7
3
2
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Glaxosmithkline LLC
529
5
Takeda Pharmaceutical Company Limited
2718
4
Kumiai Chemical Industry Co., Ltd.
313
4
Nippon Shinyaku Co., Ltd.
321
4
Merial, Inc.
211
3
Hoffmann-La Roche Inc.
3726
2
Arizona Board of Regents on behalf of Arizona State University
2875
2
Cornell University
3400
2
Dana-Farber Cancer Institute, Inc.
2645
2
Indiana University Research and Technology Corporation
780
2
Jiangsu Hengrui Medicine Co., Ltd.
695
2
Nanjing Tech University
293
2
Shanghai Hengrui Pharmaceutical Co., Ltd.
691
2
The United States of America, as represented by the Secretary, Department of Health and Human Services
2980
2
Vectus Biosystems Limited
28
2
Sanofi
4274
2
Adamed Pharma S.A.
154
2
Vitae Pharmaceuticals, LLC
41
2
Xiamen Vivohealths Technology Co., Ltd.
7
2
Plex Pharmaceuticals, Inc.
16
2
Autres propriétaires 61